Neuroprotective Effect of Brazilin on Amyloid β (25-35)-Induced Pathology in a Human Neuroblastoma Model.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
16 Jun 2020
16 Jun 2020
Historique:
received:
02
03
2020
accepted:
18
05
2020
entrez:
23
6
2020
pubmed:
23
6
2020
medline:
23
6
2020
Statut:
epublish
Résumé
Until the recent past, the sole exemplar of proteins as infectious agents leading to neurodegenerative disorders remained the prion protein. Since then, the self-seeding mechanism characteristic of the prion protein has also been attributed to other neurodegenerative-disease-associated proteins, including amyloid-β (Aβ), tau, and α-synuclein (α-Syn). In model cell line studies, truncated Aβ, viz. amyloid beta (25-35), has been found to influence cellular homeostasis through its interactions with, and via, the disruption of key housekeeping machinery. Here, we demonstrate that the incubation of human neuroblastoma (SH-SY5Y) cell line with Brazilin ((6
Identifiants
pubmed: 32566844
doi: 10.1021/acsomega.0c00396
pmc: PMC7301549
doi:
Types de publication
Journal Article
Langues
eng
Pagination
13785-13792Informations de copyright
Copyright © 2020 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Exp Mol Med. 2015 Mar 13;47:e147
pubmed: 25766616
Acta Neuropathol. 2017 Aug;134(2):187-205
pubmed: 28401333
Clin Cancer Drugs. 2016;3(2):138-146
pubmed: 27857884
Chem Commun (Camb). 2018 Aug 2;54(63):8667-8684
pubmed: 29978862
Acta Neuropathol Commun. 2018 Sep 19;6(1):96
pubmed: 30231908
Prog Neurobiol. 2017 Aug;155:171-193
pubmed: 26209472
Acta Neuropathol Commun. 2017 Dec 19;5(1):99
pubmed: 29258615
Neural Regen Res. 2018 Nov;13(11):1875-1878
pubmed: 30233055
J Neuropathol Exp Neurol. 2006 Jul;65(7):685-97
pubmed: 16825955
Bull Acad Natl Med. 2015 Jun;199(6):809-819
pubmed: 29901881
J Food Sci Technol. 2013 Aug;50(4):687-95
pubmed: 24425970
ACS Chem Neurosci. 2019 Aug 21;10(8):3346-3348
pubmed: 31305063
Cell Biol Toxicol. 2019 Dec;35(6):503-519
pubmed: 30825052
Neurology. 1996 Nov;47(5):1148-52
pubmed: 8909420
Sci Rep. 2015 Jan 23;5:7992
pubmed: 25613018
Acta Neuropathol. 2016 Apr;131(4):571-85
pubmed: 26810071
Exp Gerontol. 2015 Aug;68:13-8
pubmed: 25261765
Dement Geriatr Cogn Disord. 2014;37(5-6):315-26
pubmed: 24481207
J Biol Chem. 2018 Feb 16;293(7):2408-2421
pubmed: 29259137
Brain Res. 2009 Aug 4;1283:139-47
pubmed: 19520063
ACS Chem Neurosci. 2016 Nov 16;7(11):1519-1530
pubmed: 27635664
PLoS One. 2013 Sep 09;8(9):e73508
pubmed: 24039967
Handb Clin Neurol. 2018;153:303-319
pubmed: 29887142
Neurobiol Dis. 2018 Jan;109(Pt B):209-218
pubmed: 28751258
Brain Res. 1996 Nov 4;738(2):196-204
pubmed: 8955513
Nat Med. 2014 Feb;20(2):130-8
pubmed: 24504409
Biomacromolecules. 2004 Jul-Aug;5(4):1362-70
pubmed: 15244452
ACS Chem Neurosci. 2019 Aug 21;10(8):3343-3345
pubmed: 31290321
ACS Chem Neurosci. 2019 Sep 18;10(9):3911-3913
pubmed: 31456389
Brain Pathol. 2017 Jul;27(4):472-479
pubmed: 27495267
Biochem Mol Biol Educ. 2012 Nov-Dec;40(6):372-82
pubmed: 23166025
Int J Mol Sci. 2018 Oct 09;19(10):
pubmed: 30304819
Clin Dev Immunol. 2013;2013:473706
pubmed: 24228054
Lancet Neurol. 2017 Jan;16(1):55-65
pubmed: 27979356
Ayu. 2013 Jan;34(1):124-8
pubmed: 24049418
Nature. 2018 May;557(7706):558-563
pubmed: 29743672
Curr Cell Biochem. 2011;1(1):1-14
pubmed: 27042697
Arch Biochem Biophys. 2010 Apr 15;496(2):84-92
pubmed: 20153288
Cell Oncol (Dordr). 2016 Jun;39(3):265-77
pubmed: 26920032
J Am Chem Soc. 2001 Jun 20;123(24):5625-31
pubmed: 11403592
Front Neurosci. 2017 Nov 28;11:647
pubmed: 29234268
Sci Rep. 2019 Apr 12;9(1):6005
pubmed: 30979953
BMC Neurosci. 2014 Dec 31;15:132
pubmed: 25552352
Neurobiol Dis. 2018 May;113:1-10
pubmed: 29414379
Mol Psychiatry. 2015 Dec;20(12):1588-95
pubmed: 25687773
Neuroreport. 2012 May 30;23(8):493-7
pubmed: 22551949
Biochem Soc Trans. 2005 Nov;33(Pt 5):1082-6
pubmed: 16246050
Ann Neurol. 2003 Dec;54(6):781-9
pubmed: 14681887